3 ms·
I can't speak for the past, but I think the big deal for the testing of the future will be shifting from "forty percent of the test subjects responded positivel
by notahacker 10y ago
I can't speak for the past, but I think the big deal for the testing of the future will be shifting from "forty percent of the test subjects responded positively to the drug; none of the side effects were that bad" to "80% of test subjects carrying thought-to-be-marginally-relevant gene Y showed positive responses to the drug but none carrying gene Yvariant; those also carrying not-suspected-of-be-relevant gene X exhibited much stronger side effects"
That should make initial testing a lot more expensive, but in the long run launches of new drugs less risky.
- jonknee 10y agoAnd even farther in the long run make it possible to virtually test therapies against arbitrary genetic information.
- theptip 10y agoI've been thinking along these lines recently; we currently design treatment plans using statistical methods, i.e. averaging effects across 'representative populations'. But imagine if you took your car to the garage and they said "90% of cars showing this symptom respond well to this treatment". When we truly understand how these biological systems work (which could be more than 100 years from now) we'll be able to measure what is different from the individual's baseline, rather than extrapolating based population averages.